Your browser is no longer supported. Please, upgrade your browser.
BMRA [NASD]
Biomerica, Inc.
Index- P/E- EPS (ttm)-0.61 Insider Own16.01% Shs Outstand12.43M Perf Week4.83%
Market Cap58.53M Forward P/E16.10 EPS next Y0.31 Insider Trans0.00% Shs Float10.51M Perf Month11.38%
Income-7.30M PEG- EPS next Q0.17 Inst Own19.60% Short Float10.22% Perf Quarter17.14%
Sales7.30M P/S8.02 EPS this Y-137.00% Inst Trans-4.76% Short Ratio0.52 Perf Half Y36.71%
Book/sh0.71 P/B7.03 EPS next Y155.10% ROA-57.40% Target Price- Perf Year-23.23%
Cash/sh0.43 P/C11.71 EPS next 5Y- ROE-73.90% 52W Range3.30 - 8.15 Perf YTD0.20%
Dividend- P/FCF- EPS past 5Y-26.00% ROI-81.70% 52W High-38.77% Beta-0.63
Dividend %- Quick Ratio4.10 Sales past 5Y7.00% Gross Margin1.30% 52W Low51.21% ATR0.39
Employees49 Current Ratio6.00 Sales Q/Q18.20% Oper. Margin-99.80% RSI (14)52.28 Volatility6.43% 8.52%
OptionableYes Debt/Eq0.00 EPS Q/Q22.90% Profit Margin- Rel Volume0.04 Prev Close5.07
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume2.07M Price4.99
Recom1.00 SMA206.23% SMA50-0.64% SMA2005.65% Volume76,285 Change-1.58%
Nov-10-20Initiated Colliers Securities Buy $13
Jan-04-18Initiated B. Riley FBR, Inc. Buy $7.50
Nov-19-21 08:19AM  
Nov-04-21 06:39AM  
Oct-29-21 08:19AM  
Oct-19-21 06:39AM  
Oct-15-21 06:39AM  
Oct-12-21 06:11AM  
Oct-04-21 04:30PM  
Oct-01-21 02:51PM  
12:47PM  
11:00AM  
06:39AM  
06:15AM  
Aug-30-21 08:19AM  
Aug-13-21 01:50AM  
Aug-11-21 08:19AM  
Aug-05-21 08:19AM  
Jul-08-21 11:20AM  
Jun-24-21 08:19AM  
Jun-23-21 06:53PM  
Jun-15-21 08:19AM  
Jun-11-21 02:16AM  
Jun-04-21 08:00AM  
May-27-21 07:15PM  
May-12-21 08:30AM  
May-11-21 04:38PM  
08:19AM  
Apr-20-21 09:35AM  
Apr-15-21 10:31AM  
Apr-07-21 02:33AM  
Feb-17-21 12:23AM  
Jan-15-21 09:27AM  
Jan-13-21 10:26AM  
Jan-12-21 08:19AM  
Jan-03-21 02:06AM  
Dec-16-20 07:05AM  
Dec-09-20 08:19AM  
Oct-16-20 09:27AM  
Oct-05-20 07:16AM  
Sep-01-20 08:19AM  
Aug-31-20 05:00PM  
08:19AM  
Aug-25-20 05:51AM  
Aug-21-20 06:31AM  
Aug-13-20 10:26AM  
Aug-12-20 08:19AM  
Aug-05-20 11:15AM  
Jul-22-20 06:39AM  
Jun-29-20 09:39PM  
Jun-16-20 08:19AM  
Jun-06-20 08:01AM  
Jun-01-20 07:38AM  
May-27-20 07:20AM  
May-14-20 06:40AM  
May-07-20 10:27AM  
06:36AM  
Apr-15-20 08:30AM  
Apr-03-20 08:28PM  
09:52AM  
Apr-02-20 07:38AM  
Apr-01-20 11:43AM  
Mar-30-20 06:22AM  
Mar-19-20 07:37AM  
Mar-18-20 07:36AM  
Mar-17-20 08:16PM  
Feb-26-20 04:41PM  
Feb-13-20 05:15AM  
Jan-15-20 08:19AM  
Jan-09-20 05:45AM  
Jan-07-20 08:19AM  
Dec-04-19 07:00AM  
Oct-29-19 06:43AM  
Oct-16-19 08:19AM  
Sep-29-19 09:15AM  
Sep-19-19 10:15AM  
Aug-30-19 10:31AM  
08:30AM  
Aug-21-19 08:19AM  
Jul-25-19 11:33AM  
Jun-19-19 02:28PM  
Jun-05-19 08:19AM  
Apr-25-19 10:06AM  
Apr-22-19 11:00AM  
Apr-16-19 09:18AM  
Apr-08-19 08:19AM  
Mar-12-19 08:45AM  
Feb-21-19 02:49PM  
Feb-05-19 08:19AM  
Jan-22-19 02:42PM  
Jan-21-19 11:00AM  
Jan-15-19 08:19AM  
Nov-28-18 08:19AM  
Nov-16-18 08:55AM  
07:30AM  
Nov-07-18 09:42AM  
Oct-22-18 01:15PM  
Oct-16-18 08:30AM  
Sep-26-18 12:00PM  
Sep-07-18 10:00AM  
Aug-30-18 08:19AM  
Aug-02-18 08:19AM  
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.